Studies have shown that B3GALT5 is upregulated in breast cancer and can regulate the expression of zinc finger E‐box binding homeobox transcription factor 1 (ZEB1) as well as the activation of β‐catenin nuclear translocation, promoting the progression of breast cancer metastasis.16 Here, B3GALT5 is linked to breast carcinoma.